Vol 17, No 5 (2012)
Special Issue Papers
Published online: 2012-09-01

open access

Page views 224
Article views/downloads 214
Get Citation

Connect on Social Media

Connect on Social Media

Detection of risk factors that influence weight loss in patients undergoing radiotherapy

Jon Cacicedo1, Francisco Casquero1, Lorea Martinez-Indart2, Olga del Hoyo1, Alfonso Gómez Iturriaga1, Irma Muruzabal1, Claudia Carvajal1, Elsira Bóveda1, Blanca Ruiz1, Armando Loayza1, Begoña Usategui1, Aurora Lasso1, Eduardo Hortelano1, Pedro Bilbao1
DOI: 10.1016/j.rpor.2012.07.017
Rep Pract Oncol Radiother 2012;17(5):269-275.

Abstract

Aim

To identify risk factors that influence weight loss in patients receiving radiotherapy.

Background

It is a well-known fact that cancer patients can be affected by malnutrition at the onset of the disease and during treatment due to the toxicity. Pretreatment weight loss alone does not predict those who will need nutritional supplementation. Instead, a variety of nutritional and tumor related factors needs to be taken into account.

Material and methods

A retrospective study was conducted on 129 patients with different tumor locations. Weight loss was evaluated during radiotherapy and one month after treatment. The impact of age, ECOG, chemotherapy, pretreatment weight loss, tumor location, previous surgery and TNM were analyzed. We aimed to identify a high-risk group of patients before starting treatment.

Results

The average net weight loss during radiotherapy and one month after treatment for this group of patients was 0.68[[ce:hsp sp="0.25"/]]kg and 1.6[[ce:hsp sp="0.25"/]]kg, respectively. Median weight loss during radiotherapy was 2.6 kg for head and neck (HN) patients and 0.27 [[ce:hsp sp="0.25"/]]kg for other tumor sites (p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.028). Median weight loss one month after radiotherapy was 3.7[[ce:hsp sp="0.25"/]]kg for HN patients and 1.1[[ce:hsp sp="0.25"/]]kg for the rest of the patients (p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.034). The median weight loss one month after treatment was 3.2 kg for patients receiving chemotherapy and 0.5[[ce:hsp sp="0.25"/]]kg for those patients who did not receive chemotherapy (p[[ce:hsp sp="0.25"/]]<[[ce:hsp sp="0.25"/]]0.001). A regression analysis determined that HN tumor location and the use of chemotherapy were independent risk factors.

Conclusions

Nutritional status must be monitored and managed before, during and after treatment. A variety of nutritional and tumor-related factors must be considered. According to our results, head and neck tumors and the use of chemotherapy are the only two factors considered statistically significant. Because patients continue to lose weight after treatment, we recommend close surveillance after radiotherapy.

Article available in PDF format

View PDF Download PDF file